Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
InfoPack
Recent JCP Articles on InfoPack
JCP
InfoPack
Emerging Treatments in Schizophrenia
February 15, 2022
Experts discuss the brain circuits involved in schizophrenia, the current medications, and new agents in phase 3 trials that do not directly block postsynaptic D2 receptors. Phase 2 data...
Christoph U. Correll
,
Anissa Abi-Dargham
,
Oliver Howes
JCP
InfoPack
Improving Outcomes in Patients With Bipolar Depression: A Comprehensive Review
March 25, 2015
Andrew A. Nierenberg
,
Gary S. Sachs
,
Roger S. McIntyre
JCP
InfoPack
Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes
August 26, 2014
Mark Olfson
,
John M. Kane
,
Christoph U. Correll
, et al
Recent PCC Articles on InfoPack
JCP
Original Research
NNT, NNH, and LLH for Aripiprazole Once-Monthly in Schizophrenia
May 13, 2026
Data demonstrate a favorable benefit-risk profile for aripiprazole once-monthly 400 vs placebo in acute and maintenance treatment of schizophrenia.
Leslie Citrome
,
Karimah S. Bell Lynum
,
Zhen Zhang
, et al
JCP
Original Research
▶ Video
Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation
May 13, 2026
A single psilocybin dose with psychological support was associated with rapid, large, and durable reductions in suicidal ideation and depressive symptoms.
Andrew van der Vaart
,
Jeffrey LaPratt
,
Kimberly Swartz
, et al
PCC
Rounds in the General Hospital
Differentiating Bipolar and Other Psychiatric Disorders
May 12, 2026
Diagnosis of bipolar spectrum disorder is often complicated, as most patients present for care during depressive episodes, which are more frequent than hypomanic or manic episodes.
Mohamed Soliman
,
Sharmin Ghaznavi
,
David Mischoulon
, et al
Featured
InfoPack Research
PCC
Letter to the Editor
Take “Oedipus” Off
May 12, 2026
The authors examine justification for using the name of Oedipus to identify a psychoanalytic concept concerning children aged 3–6 years describing attraction to the parent of the opposite sex...
Ahmed Naguy
,
Saxby Pridmore
JCP
Original Research
Effects of Experimental Intermittent Theta Burst Stimulation on Negative Symptoms of Schizophrenia
May 11, 2026
Findings suggest limited efficacy of experimental intermittent theta burst stimulation over the left DLPFC for negative symptoms.
Nand Kumar
,
Shiv Prasad
,
M. V. Padma Srivastava
, et al
PCC
Case Report
Aripiprazole-Induced Pathological Gambling
May 7, 2026
A 27-year-old man with a history of substance abuse developed a new-onset compulsive gambling pattern within weeks of starting aripiprazole.
Marta Ribeiro
,
Ana Lourenço
,
Inês Chaves
